Pharmacokinetic and pharmacodynamic changes in older adults and implications for palliative care

References

• World Population Prospects: The 2012 Revision, Volume II, Demographic Profiles. United Nations, Department of Economic and Social Affairs, Population Division; 2013. Report No.: ST/ESA/SER.A/345.
   Google Scholar
• McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004;56(2):163–84. doi: 10.1124/pr.56.2.4
   PubMed Web of Science ®Google Scholar
• Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev 2009;41(2):67–76. doi: 10.1080/03602530902722679
   PubMed Web of Science ®Google Scholar
• Cusack BJ. Pharmacokinetics in older persons. Am J Geriatr Pharmcother 2004;2:274–302. doi: 10.1016/j.amjopharm.2004.12.005
   PubMedGoogle Scholar
• Rowland M, Tozer, TN. Clinical pharmacokinetics and pharmacodynamics: concepts and applications. 4th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2010. p.864.
   Google Scholar
• Shi S, Klotz U. Age-related changes in pharmacokinetics. Curr Drug Metab 2011;12(7):601–10. doi: 10.2174/138920011796504527
   PubMed Web of Science ®Google Scholar
• Kaestli LZ, Wasilewski-Rasca AF, Bonnabry P, Vogt-Ferrier N. Use of transdermal drug formulations in the elderly. Drugs Aging 2008;25(4):269–80. doi: 10.2165/00002512-200825040-00001
   PubMed Web of Science ®Google Scholar
• Thompson JP, Bower S, Liddle AM, Rowbotham DJ. Perioperative pharmacokinetics of transdermal fentanyl in elderly and young adult patients. Br J Anaesth 1998;81(2):152–4. doi: 10.1093/bja/81.2.152
   PubMed Web of Science ®Google Scholar
• Kharasch ED, Hoffer C, Whittington D. Influence of age on the pharmacokinetics and pharmacodynamics of oral transmucosal fentanyl citrate. Anesthesiology 2004;101(3):738–43. doi: 10.1097/00000542-200409000-00023
   PubMed Web of Science ®Google Scholar
• Turnheim K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 2003 Aug;38(8):843–53. doi: 10.1016/S0531-5565(03)00133-5
   PubMed Web of Science ®Google Scholar
• Delafuente JC. Pharmacokinetic and pharmacodynamic alterations in the geriatric patient. Consult Pharm 2008;23(4):324–34. doi: 10.4140/TCP.n.2008.324
   PubMedGoogle Scholar
• Benet LZ, Hoener BA. Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther 2002;71(3):115–21. doi: 10.1067/mcp.2002.121829
   PubMed Web of Science ®Google Scholar
• Le Couteur DG, McLean AJ. The aging liver: drug clearance and an oxygen diffusion barrier hypothesis. Clin Pharmacokinet 1998;34(5):359–67. doi: 10.2165/00003088-199834050-00003
   PubMed Web of Science ®Google Scholar
• Bigos KL, Pollock BG, Coley KC, Miller DD, Marder SR, Aravagiri M, et al. Sex, race, and smoking impact olanzapine exposure. J Clin Pharmacol 2008;48(2):157–65. doi: 10.1177/0091270007310385
   PubMed Web of Science ®Google Scholar
• Kaye CM, Nicholls B. Clinical pharmacokinetics of ropinirole. Clin Pharmacokinet 2000;39(4):243–54. doi: 10.2165/00003088-200039040-00001
   PubMed Web of Science ®Google Scholar
• Feng Y, Pollock BG, Ferrell RE, Kimak MA, Reynolds CF, Bies RR. Paroxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling. Br J Clin Pharmacol 2006;61(5):558–69. doi: 10.1111/j.1365-2125.2006.02629.x
   PubMed Web of Science ®Google Scholar
• Ishizawa Y, Yasui-Furukori N, Takahata T, Sasaki M, Tateishi T. The effect of aging on the relationship between the cytochrome P450 2C19 genotype and omeprazole pharmacokinetics. Clin Pharmacokinet 2005;44(11):1179–89. doi: 10.2165/00003088-200544110-00005
   PubMed Web of Science ®Google Scholar
• Turnheim K. Drug therapy in the elderly. Exp Gerontol 2004;39(11–12):1731–8. doi: 10.1016/j.exger.2004.05.011
   PubMed Web of Science ®Google Scholar
• ElDesoky ES. Pharmacokinetic-pharmacodynamic crisis in the elderly. Am J Ther 2007;14(5):488–98. doi: 10.1097/01.mjt.0000183719.84390.4d
   PubMedGoogle Scholar
• Aymanns C, Keller F, Maus S, Hartmann B, Czock D. Review on pharmacokinetics and pharmacodynamics and the aging kidney. Clin J Am Soc Nephrol 2010;5(2):314–27. doi: 10.2215/CJN.03960609
   PubMed Web of Science ®Google Scholar
• Muhlberg W, Platt D. Age-dependent changes of the kidneys: pharmacological implications. Gerontology. 1999;45(5):243–53. doi: 10.1159/000022097
   PubMed Web of Science ®Google Scholar
• Bowie MW, Slattum PW. Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother 2007;5(3):263–303. doi: 10.1016/j.amjopharm.2007.10.001
   PubMedGoogle Scholar
• Albrecht S, Ihmsen H, Hering W, Geisslinger G, Dingemanse J, Schwilden H, et al. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. Clin Pharmacol Ther 1999;65(6):630–9. doi: 10.1016/S0009-9236(99)90084-X
   PubMed Web of Science ®Google Scholar
• Robin DW, Hasan SS, Edeki T, Lichtenstein MJ, Shiavi RG, Wood AJ. Increased baseline sway contributes to increased losses of balance in older people following triazolam. J Am Geriatr Soc 1996;44(3):300–4. doi: 10.1111/j.1532-5415.1996.tb00919.x
   PubMed Web of Science ®Google Scholar
• Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM. Prescribing in palliative care as death approaches. J Am Geriatr Soc 2007;55:590–5. doi: 10.1111/j.1532-5415.2007.01124.x
   PubMed Web of Science ®Google Scholar
• Caltagirone C, Spoletini I, Gianni W, Spalletta G. Inadequate pain relief and consequences in oncological elderly patients. Surgical Oncol 2010;19:178–83. doi: 10.1016/j.suronc.2009.11.009
   PubMed Web of Science ®Google Scholar
• Malec M, Shega JW. Pain management in the elderly. Med Clin N Am [Internet] 2015;99:337–50. doi: 10.1016/j.mcna.2014.11.007
   PubMed Web of Science ®Google Scholar
• De Cicco M, Bortolussi R, Fantin D, Matovic M, Fracasso A, Fabiani F, et al. Supportive therapy of elderly cancer patients. Crit Rev Oncol/Hematol 2002;42:189–211. doi: 10.1016/S1040-8428(01)00162-7
   PubMed Web of Science ®Google Scholar
• AGS Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009;57:1331–46. doi: 10.1111/j.1532-5415.2009.02376.x
   PubMed Web of Science ®Google Scholar
• Barkin RL, Beckerman M, Blum SL, Clark FM, Koh E, Wu DS. Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult? Drugs Aging 2010;27(10):775–89. doi: 10.2165/11539430-000000000-00000
   PubMed Web of Science ®Google Scholar
• Pilotto A, Franseschi M, Leandro G, Paris F, Cascavilla L, Longo MG, et al. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2004;20:1091–7. doi: 10.1111/j.1365-2036.2004.02246.x
   PubMed Web of Science ®Google Scholar
• Makris UE, Abrams RC, Gurlund B, Carrington Reid M. Management of persistent pain in the older patient: a clinical review. JAMA [Internet] 2014 Aug 27;312(8):825–36. doi: 10.1001/jama.2014.9405
   PubMed Web of Science ®Google Scholar
• Wallace J, Paauw DS. Appropriate prescribing and important drug interactions in older adults. Med Clin N Am [Internet] 2015;99:295–310. doi: 10.1016/j.mcna.2014.11.005
   PubMed Web of Science ®Google Scholar
• Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of the international expert panel with focus on the six clinically most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 2008;8(4):287–313. doi: 10.1111/j.1533-2500.2008.00204.x
   PubMedGoogle Scholar
• Thorlund K, Druyts E, Wu P, Balijepalli C, Keohane D, Mills E. Comparative efficacy of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors in older adults: a network meta-analysis. J Am Geriatr Soc 2015;63:1002–9. doi: 10.1111/jgs.13395
   PubMed Web of Science ®Google Scholar
• The American Geriatrics Society. American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012;60:616–31. doi: 10.1111/j.1532-5415.2012.03923.x
   PubMed Web of Science ®Google Scholar
• Duncan NA, Mahan RJ, Turner SJ. Non-opiate pharmacotherapy options for the management of pain in older adults. Ment Health Clin [Internet] 2015;5(3):91–101. Doi:10.9740/mhc.2015.05.091.
   Google Scholar
• Glare P, Miller J, Nikolova T, Tickoo R. Treating nausea and vomiting in palliative care: a review. Clin Interv Aging 2011;6:243–59. doi: 10.2147/CIA.S13109
   PubMed Web of Science ®Google Scholar